Vitrolife Stock
StockStockPrice
Historical dividends and forecast
Vitrolife has so far distributed $0.0927 in 2024. The next dividend will be paid on 03.05.2025
CHART BY
Frequently asked questions
What is Vitrolife's market capitalization?
What is the Earnings Per Share (EPS) for Vitrolife?
What are the analyst ratings and target price for Vitrolife's stock?
What is Vitrolife's revenue over the trailing twelve months?
What is the EBITDA for Vitrolife?
What is the free cash flow of Vitrolife?
What is the 5-year beta of Vitrolife's stock?
How many employees does Vitrolife have, and what sector and industry does it belong to?
What is the free float of Vitrolife's shares?
Financials
Market Cap
$2.99B5Y beta
2.12EPS (TTM)
-$2.575Free Float
75.05MRevenue (TTM)
$325.67MEBITDA (TTM)
$109.69MFree Cashflow (TTM)
$47.65MPricing
Analyst Ratings
The price target is $20.96 and the stock is covered by 3 analysts.
Buy
2
Hold
1
Sell
0
Information
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
1,100
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker